EVALUATION OF THE SAFETY AND EFFICACY OF THE FIRST-LINE TREATMENT WITH SOMATOSTATIN COMBINED WITH MELATONIN, RETINOIDS, VITAMIN D3, AND LOW DOSES OF CYCLOPHOSPHAMIDE IN 20 CASES OF BREAST CANCER: A PRELIMINARY REPORT

DI BELLA, G., MASCIA, F., & RICCHI, A.. (2013). EVALUATION OF THE SAFETY AND EFFICACY OF THE FIRST-LINE TREATMENT WITH SOMATOSTATIN COMBINED WITH MELATONIN, RETINOIDS, VITAMIN D3, AND LOW DOSES OF CYCLOPHOSPHAMIDE IN 20 CASES OF BREAST CANCER: A PRELIMINARY REPORT. NEURO ENDOCRINOLOGY LETTER, 34(7), 660-668. SID. https://sid.ir/paper/656755/en

DI BELLA G., MASCIA F., RICCHI A.. EVALUATION OF THE SAFETY AND EFFICACY OF THE FIRST-LINE TREATMENT WITH SOMATOSTATIN COMBINED WITH MELATONIN, RETINOIDS, VITAMIN D3, AND LOW DOSES OF CYCLOPHOSPHAMIDE IN 20 CASES OF BREAST CANCER: A PRELIMINARY REPORT. NEURO ENDOCRINOLOGY LETTER[Internet]. 2013;34(7):660-668. Available from: https://sid.ir/paper/656755/en

G. DI BELLA, F. MASCIA, and A. RICCHI, “EVALUATION OF THE SAFETY AND EFFICACY OF THE FIRST-LINE TREATMENT WITH SOMATOSTATIN COMBINED WITH MELATONIN, RETINOIDS, VITAMIN D3, AND LOW DOSES OF CYCLOPHOSPHAMIDE IN 20 CASES OF BREAST CANCER: A PRELIMINARY REPORT,” NEURO ENDOCRINOLOGY LETTER, vol. 34, no. 7, pp. 660–668, 2013, [Online]. Available: https://sid.ir/paper/656755/en